Skip to content

biofeedback physical regulation of post-ischemic stroke with spastic hypertonia based on acupoints: a clinical trial

biofeedback physical regulation of post-ischemic stroke with spastic hypertonia based on acupoints: a clinical trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200067186
Enrollment
Unknown
Registered
2022-12-29
Start date
2023-01-10
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-ischemic stroke with spastic hypertonia

Interventions

High Frequency Group:tDCS+TEAS-100Hz+Routine rehabilitation training
Low Frequency Group:tDCS+TEAS-20Hz+Routine rehabilitation training
Usual Care Group:Routine rehabilitation training

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients with first-onset ischemic stroke confirmed by CT or MRI with an onset of more than 1 month. (2) Clinical symptoms of unilateral limb paralysis and motor dysfunction of upper and lower limbs. (3) MAS rating of grade I or above for the major involved joint of the limb. (4) Able to walk independently without the assistance of a walker for 10 meters. (5) Age 18-70 years old, male and female gender is not limited. (6) Stable condition, consciousness, hearing and comprehension without impairment, and able to complete the questionnaire. (7) Voluntary participation and signed informed consent form.

Exclusion criteria

Exclusion criteria: (1) Serious medical diseases such as heart, liver, kidney, tumor and other malignant diseases, infectious diseases and psychiatric diseases. (2) Contraindications to the use of electrical stimulators: placement of metallic or electronic implantable devices (such as pacemakers); history of epilepsy; history of head trauma or head or spinal cord surgery; bleeding disorders; pregnancy or lactation or intended pregnancy within the next 6 months; skin lesions, inflammation, scarring, etc. at acupuncture points; sensory impairment or allergy to electrical stimulation, etc. (3) Patients who have taken muscle relaxant drugs in the past month. (4) Patients who have received acupuncture, transcranial electrical stimulation or transcutaneous electrical stimulation treatment in the past six months.

Design outcomes

Primary

MeasureTime frame
modified Ashworth scale(MAS);

Secondary

MeasureTime frame
integrated EMG(iEMG);co-contraction ratio(CR);Fugl-Meyer Motor Function Assessment;modified Barthel index(MBI);10 Meter Walk Test;

Countries

China

Contacts

Public ContactMa Liangxiao

School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine

maliangxiao@vip.sina.com+86 13301188102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026